Elif Kale Bakir

Elif Kale Bakir

Auto-generated profile, based on publicly available information

Elif Kale Bakir

Department of Biology, Faculty of Arts and Sciences, Kocaeli University, Baki Komsuoglu Bulvari, 41001, Kocaeli, Türkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2025 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
EBElif Kale Bakir
Elif Kale Bakir
AOAsuman Deveci Ozkan
Asuman Deveci Ozkan
GEGÜLAY ERMAN
GÜLAY ERMAN
SISemih Isik
Semih Isik
Yonca Yuzugullu KarakusYonca Yuzugullu Karakus
Yonca Yuzugullu Karakus

18 January 2026 in Food Chemistry
Verified
Journal Article
Closed access
Yonca Yuzugullu KarakusYonca Yuzugullu Karakus
Yonca Yuzugullu Karakus
EBElif Kale Bakir
Elif Kale Bakir
DSDidem Ülgüt Sakallıoğlu
Didem Ülgüt Sakallıoğlu
ICİlAyda Candan
İlAyda Candan
AYAyşegül Yörük
Ayşegül Yörük

30 December 2022 in Kahramanmaraş Sütçü İmam Üniversitesi Tarım ve Doğa Dergisi
Verified
Journal Article
Open access
BMBektore Mansurov
Bektore Mansurov
EKElif Kale
Elif Kale
AAArda Acemi
Arda Acemi
Yonca Yuzugullu KarakusYonca Yuzugullu Karakus
Yonca Yuzugullu Karakus
This study aimed to purify and biochemically characterize polyphenol oxidase (PPO) enzyme from the plant Ipomoea purpurea (I. purpurea) for the first time. For this purpose, the crude extract sample obtained from the extraction of in vitro cultured plant leaves under optimum conditions (25 mgmL-1 Polyvinylpolypyrrolidone, pH 7.0) was subjected to three-phase partitioning, and the PPO enzyme was 10.5-fold purified with a 57% activity recovery. The optimum pH and temperature values were determined as 7.0 and 30°C, respectively. Laccase, peroxidase, and catechol oxidase activities were observed after activity staining of partially purified enzyme. From stability tests, it was noted that more than 75% and 65% of its original activity were maintained at temperatures 20℃-40℃ and pH 7.0-9.0, respectively.

30 September 2019 in CBU International Conference Proceedings
Verified
Journal Article
Open access
PDF file
EKElif Kale
Elif Kale
ASAlaattin SEN
Alaattin SEN
Mesalamine [5-aminosalicylic acid (5-ASA)] is a substantial supportive agent in the treatment of inflammatory bowel diseases (IBD), particularly in ulcerative colitis (UC). It is well known that 5-ASA is metabolized by phase II enzymes. And most likely cytochrome P450 enzymes have an important role in this process. However, there is no information to the accuracy of this and which CYP isoforms affect this potential pathway of metabolism. In this study, it was aimed to find out whether other alternative drug metabolism pathways other than N-acetylation, are involved in 5-ASA metabolism, particularly cytochrome P450s. For this purpose, first, a colorimetric method was developed to measure the 5-ASA. Then, it was applied to determine whether mesalamine was metabolized by in vitro with each pure CYP450 isozymes (CYP1A2, CYP2C9, CYP3A4, CYP2C19, CYP2D6). It has shown that 5-ASA acted as a substrate for the CYP3A4 and CYP2D6 isoforms. The incubation of pure CYP isoforms in the presence of prototype substrates together with 5-ASA have led to inhibition of prototype activities of CYP3A4 and CYP1A2. As a consequence, this study demonstrated that the 5-ASA is both a substrate and an inhibitor for CYP3A4, a substrate for CYP2D6, and an inhibitor for CYP1A2. Thus, the prescription of mesalamine together with the drugs metabolized with these CYP isozymes could cause unanticipated adverse reactions or therapeutic failures. These are the new contributions to the literature.

15 April 2025 in Trakya University Journal of Natural Sciences
Verified
Journal Article
Open access
PDF file
EBElif Kale Bakır
Elif Kale Bakır
AOAsuman Deveci Ozkan
Asuman Deveci Ozkan
ÖAÖzlem Aksoy
Özlem Aksoy
Yonca Yuzugullu KarakusYonca Yuzugullu Karakus
Yonca Yuzugullu Karakus
The coelomic fluid of the red California earthworm Eisenia foetida (Sav.) includes a number of bioactive substances with antitumor and protective effects, thus making the fluid to also act as a defensive agent for the organism. Eisenia foetida coelomic fluid can be used as an alternative medication, for it is readily available and has few adverse effects. Metformin are widely used for managing type 2 diabetes mellitus by improving insulin sensitivity and reducing hepatic glucose production; however, therapeutic dose-related adverse effects have been reported. The present investigation aims to determine, for the first time, the protective effects of E. foetida coelomic fluid against possible metformin toxicity at the molecular and cellular levels. Metformin-induced cell toxicity was conducted following E. foetida coelomic fluid pre-treatment in Human Umbilical Vein Endothelial Cells (HUVEC). In addition to cell and nuclear morphology observation, a decrease in reactive oxygen species and apoptotic cell rate was determined. According to the obtained findings, the coelomic fluid of E. foetida preserved cell viability and morphology, reduced reactive oxygen species and apoptosis cell death, and enhanced anti-apoptotic mRNA expressions. When treating diseases, medical support and adjunct therapies should be taken into account. In this sense, our present preliminary in vitro findings showed that E. foetida coelomic fluid might has great additional treatment potential, and further molecular and animal studies to support this effect are needed.

1 June 2026 in Kocaeli Journal of Science and Engineering
Verified
Journal Article
Closed access
SÇSimge Çolak
Simge Çolak
SISemih Işık
Semih Işık
EBElif Kale Bakır
Elif Kale Bakır
Yonca Yuzugullu KarakusYonca Yuzugullu Karakus
Yonca Yuzugullu Karakus
This study focuses on developing a high-efficiency, cost-effective three-phase partitioning (TPP) purification strategy for polyphenol oxidase (PPO) from black mulberry (Morus nigra) fruit, known for its rich antioxidant profile. Reaction conditions were optimized, and maximum PPO activity was achieved in a system containing 100 mM sodium phosphate buffer (pH 7.0), 10 mM ascorbic acid, 0.5% (w/v) PEG 6000, and 50 mM K₂HPO₄. Under optimized TPP conditions, PPO was purified with an exceptionally high activity recovery of 177% and a 2.7-fold increase in purity, demonstrating the efficiency of this approach compared with conventional purification strategies. The methodological simplicity, scalability, and environmentally friendly nature of the process highlight its potential as a practical alternative for enzyme purification from natural sources. Overall, this study provides a cost-effective, efficient protocol for PPO recovery, offering significant industrial relevance for food biotechnology.